• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性渗出性淋巴瘤中的细胞和 KSHV A-to-I RNA 编辑组及其在病毒生命周期中的作用。

The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle.

机构信息

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232-2363, USA.

Vanderbilt Institute for Infection, Immunology and Inflammation, Nashville, TN, 37232-2363, USA.

出版信息

Nat Commun. 2023 Mar 13;14(1):1367. doi: 10.1038/s41467-023-37105-8.

DOI:10.1038/s41467-023-37105-8
PMID:36914661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10011561/
Abstract

Adenosine-to-inosine RNA editing is a major contributor to transcriptome diversity in animals with far-reaching biological consequences. Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of several human malignancies including primary effusion lymphoma (PEL). The extent of RNA editing within the KSHV transcriptome is unclear as is its contribution to the viral lifecycle. Here, we leverage a combination of biochemical and genomic approaches to determine the RNA editing landscape in host- and KSHV transcriptomes during both latent and lytic replication in PEL. Analysis of RNA editomes reveals it is dynamic, with increased editing upon reactivation and the potential to deregulate pathways critical for latency and tumorigenesis. In addition, we identify conserved RNA editing events within a viral microRNA and discover their role in miRNA biogenesis as well as viral infection. Together, these results describe the editome of PEL cells as well as a critical role for A-to-I editing in the KSHV lifecycle.

摘要

腺嘌呤到肌苷的 RNA 编辑是动物转录组多样性的主要贡献者,具有深远的生物学后果。卡波济肉瘤相关疱疹病毒 (KSHV) 是几种人类恶性肿瘤的病原体,包括原发性渗出性淋巴瘤 (PEL)。KSHV 转录组中的 RNA 编辑程度尚不清楚,其对病毒生命周期的贡献也不清楚。在这里,我们利用生化和基因组方法的组合,在 PEL 潜伏和裂解复制过程中确定宿主和 KSHV 转录组中的 RNA 编辑景观。RNA 编辑组分析表明,它是动态的,在重新激活时编辑增加,并且有可能使与潜伏期和肿瘤发生相关的途径失活。此外,我们在病毒 microRNA 内鉴定出保守的 RNA 编辑事件,并发现它们在 miRNA 生物发生以及病毒感染中的作用。总之,这些结果描述了 PEL 细胞的编辑组以及 A-to-I 编辑在 KSHV 生命周期中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/1e6dd50801da/41467_2023_37105_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/90ff7348fc0c/41467_2023_37105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/662f7d9df681/41467_2023_37105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/ab58303a821a/41467_2023_37105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/be8cbe0d0671/41467_2023_37105_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/1e6dd50801da/41467_2023_37105_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/90ff7348fc0c/41467_2023_37105_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/662f7d9df681/41467_2023_37105_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/ab58303a821a/41467_2023_37105_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/be8cbe0d0671/41467_2023_37105_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/10011561/1e6dd50801da/41467_2023_37105_Fig5_HTML.jpg

相似文献

1
The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle.原发性渗出性淋巴瘤中的细胞和 KSHV A-to-I RNA 编辑组及其在病毒生命周期中的作用。
Nat Commun. 2023 Mar 13;14(1):1367. doi: 10.1038/s41467-023-37105-8.
2
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.通过靶向卡波氏肉瘤相关疱疹病毒潜伏和裂解复制,重新利用阿糖胞苷治疗原发性渗出性淋巴瘤。
mBio. 2018 May 8;9(3):e00756-18. doi: 10.1128/mBio.00756-18.
3
ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.ARID3B:卡波西肉瘤相关疱疹病毒裂解周期的新型调节因子
J Virol. 2016 Sep 29;90(20):9543-55. doi: 10.1128/JVI.03262-15. Print 2016 Oct 15.
4
Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional superenhancers and enhancer RNAs.KSHV 感染性原发性渗出性淋巴瘤的全基因组表观遗传学分析鉴定功能超级增强子和增强子 RNA。
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21618-21627. doi: 10.1073/pnas.1922216117. Epub 2020 Aug 18.
5
The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.多聚腺苷酸化核 RNA 的表达和核保留元件不是卡波氏肉瘤相关疱疹病毒有效裂解复制所必需的。
J Virol. 2021 Jun 10;95(13):e0009621. doi: 10.1128/JVI.00096-21.
6
Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.卡波西肉瘤相关疱疹病毒K15P蛋白在原发性渗出性淋巴瘤细胞潜伏和裂解再激活过程中的表达及亚细胞定位
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.01370-17. Print 2017 Nov 1.
7
Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.激活的Nrf2与卡波西肉瘤相关疱疹病毒潜伏蛋白LANA-1和宿主蛋白KAP1相互作用,介导整体裂解基因抑制。
J Virol. 2015 Aug;89(15):7874-92. doi: 10.1128/JVI.00895-15. Epub 2015 May 20.
8
CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.CRISPR/Cas9 靶向病毒 microRNA 促进卡波西肉瘤相关疱疹病毒的裂解性再激活。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1400-1405. doi: 10.1016/j.bbrc.2020.10.030. Epub 2020 Oct 19.
9
miRNAs and their roles in KSHV pathogenesis.miRNAs 及其在 KSHV 发病机制中的作用。
Virus Res. 2019 Jun;266:15-24. doi: 10.1016/j.virusres.2019.03.024. Epub 2019 Apr 2.
10
Regulation of KSHV Latency and Lytic Reactivation.调控卡波氏肉瘤相关疱疹病毒潜伏和裂解性再激活。
Viruses. 2020 Sep 17;12(9):1034. doi: 10.3390/v12091034.

引用本文的文献

1
Non-Coding RNAs and Immune Evasion in Human Gamma-Herpesviruses.人类γ-疱疹病毒中的非编码RNA与免疫逃逸
Viruses. 2025 Jul 17;17(7):1006. doi: 10.3390/v17071006.
2
ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication.ADAR1 p150可防止单纯疱疹病毒1型触发PKR/eIF2α介导的翻译停滞,并且是病毒有效复制所必需的。
PLoS Pathog. 2025 Apr 8;21(4):e1012452. doi: 10.1371/journal.ppat.1012452. eCollection 2025 Apr.
3
RNA Modifications and Their Role in Regulating KSHV Replication and Pathogenic Mechanisms.

本文引用的文献

1
The impact of RNA modifications on the biology of DNA virus infection.RNA 修饰对 DNA 病毒感染生物学的影响。
Eur J Cell Biol. 2022 Jun-Aug;101(3):151239. doi: 10.1016/j.ejcb.2022.151239. Epub 2022 May 21.
2
The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity.RNA修饰在抗病毒天然免疫调节中的新作用
Front Microbiol. 2022 Feb 3;13:845625. doi: 10.3389/fmicb.2022.845625. eCollection 2022.
3
Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
RNA修饰及其在调控卡波西肉瘤相关疱疹病毒复制和致病机制中的作用。
J Med Virol. 2025 Jan;97(1):e70140. doi: 10.1002/jmv.70140.
4
Advances in A-to-I RNA editing in cancer.癌症中A到I RNA编辑的进展。
Mol Cancer. 2024 Dec 27;23(1):280. doi: 10.1186/s12943-024-02194-6.
5
Rationalizing the effects of RNA modifications on protein interactions.使RNA修饰对蛋白质相互作用的影响合理化。
Mol Ther Nucleic Acids. 2024 Nov 15;35(4):102391. doi: 10.1016/j.omtn.2024.102391. eCollection 2024 Dec 10.
6
A comprehensive atlas of pig RNA editome across 23 tissues reveals RNA editing affecting interaction mRNA-miRNAs.猪 RNA 编辑组图谱综合分析 23 种组织,揭示影响 mRNA- miRNA 相互作用的 RNA 编辑。
G3 (Bethesda). 2024 Oct 7;14(10). doi: 10.1093/g3journal/jkae178.
7
[Not Available].[无可用内容]。
Clin Transl Med. 2024 Jun;14(6):e1666. doi: 10.1002/ctm2.1666.
8
RNA editing enzymes: structure, biological functions and applications.RNA编辑酶:结构、生物学功能及应用
Cell Biosci. 2024 Mar 16;14(1):34. doi: 10.1186/s13578-024-01216-6.
9
RNA Editing-Dependent and -Independent Roles of Adenosine Deaminases Acting on RNA Proteins in Herpesvirus Infection-Hints on Another Layer of Complexity.腺苷脱氨酶作用于 RNA 蛋白在疱疹病毒感染中的 RNA 编辑依赖性和非依赖性作用——提示另一层复杂性。
Viruses. 2023 Sep 27;15(10):2007. doi: 10.3390/v15102007.
10
The Role of RNA Sensors in Regulating Innate Immunity to Gammaherpesviral Infections.RNA 传感器在调控γ疱疹病毒感染固有免疫中的作用。
Cells. 2023 Jun 17;12(12):1650. doi: 10.3390/cells12121650.
腺苷脱氨酶 ADAR1 中的突变阻止内源性 Z-RNA 结合,诱导 Aicardi-Goutières 综合征样脑病。
Immunity. 2021 Sep 14;54(9):1976-1988.e7. doi: 10.1016/j.immuni.2021.08.022.
4
Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.解耦 ADAR1 p150 和 p110 异构体的表达和编辑偏好。
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2021757118.
5
Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.病毒RNA的表观转录组学(N6-甲基腺苷)修饰与病毒-宿主相互作用
Front Cell Infect Microbiol. 2020 Nov 24;10:584283. doi: 10.3389/fcimb.2020.584283. eCollection 2020.
6
It's the Little Things (in Viral RNA).(在病毒 RNA 中)是那些小细节。
mBio. 2020 Sep 15;11(5):e02131-20. doi: 10.1128/mBio.02131-20.
7
A-to-I RNA editing as a tuner of noncoding RNAs in cancer.A-to-I RNA 编辑作为癌症中非编码 RNA 的调节剂。
Cancer Lett. 2020 Dec 1;494:88-93. doi: 10.1016/j.canlet.2020.08.004. Epub 2020 Aug 19.
8
Non-Coding RNA Editing in Cancer Pathogenesis.癌症发生过程中的非编码RNA编辑
Cancers (Basel). 2020 Jul 8;12(7):1845. doi: 10.3390/cancers12071845.
9
ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway.ADAR1 通过调节 RLR 依赖的信号通路促进 KSHV 裂解性再激活。
Cell Rep. 2020 Apr 28;31(4):107564. doi: 10.1016/j.celrep.2020.107564.
10
ADAR1: "Editor-in-Chief" of Cytoplasmic Innate Immunity.ADAR1:细胞质先天免疫的“总编辑”。
Front Immunol. 2019 Jul 25;10:1763. doi: 10.3389/fimmu.2019.01763. eCollection 2019.